Early research (Phase 1)Study completedNCT05326516
What this trial is testing
Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia
Who this might be right for
Relapsed/Refractory LeukemiasAcute Lymphoblastic LeukemiaAcute Lymphocytic Leukemia+3 more
Syndax Pharmaceuticals 30